Doubling time of thymic epithelial tumours on CT: correlation with histological subtype

Eur Radiol. 2017 Oct;27(10):4030-4036. doi: 10.1007/s00330-017-4795-y. Epub 2017 Mar 22.

Abstract

Objectives: We retrospectively evaluated the doubling time (DT) of thymic epithelial tumours (TET) according to the histological subtype on CT.

Methods: From January 2005 to June 2016, we enrolled 53 patients who had pathologically confirmed TET and at least two CT scans. Tumour size was measured using a two-dimensional method, and the DT was calculated. DTs were compared among histological subtypes, and factors associated with rapid tumour growth (DT <180 days) were assessed.

Results: In 42 of the 53 patients (79.2%) the tumours showed interval growth (>2 mm) during follow-up. The median DT for all tumours was 400 days (range 48-1,964 days). There were no significant differences in DT in relation to histological subtype (p = 0.177). When TETs were recategorized into three groups, i.e. low-risk thymomas (types A, AB, B1), high-risk thymomas (types B2, B3), and thymic carcinoma, DT was significantly different among the groups (median DT 436, 381 and 189 days, respectively; p = 0.031). Histological subtype (type B3 and thymic carcinoma) was the single independent predictor of rapid tumour growth.

Conclusions: The majority of TETs grew during follow-up with variable and relatively slow growth rates. Histological features of aggressive behaviour significantly correlated with a decreased DT and rapid growth.

Key points: • The majority of thymic epithelial tumours grew during follow-up (79.2%, 42/53). • Doubling times of thymic epithelial tumours were highly variable (median 400 days). • Histological features of aggressive behaviour significantly correlated with a decreased doubling time.

Keywords: Computed tomography; Correlation; Doubling time; Histological subtype; Thymic epithelial tumour.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Disease Progression
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasms, Glandular and Epithelial / diagnostic imaging
  • Neoplasms, Glandular and Epithelial / pathology*
  • Retrospective Studies
  • Risk Factors
  • Thymoma / diagnostic imaging
  • Thymoma / pathology*
  • Thymus Neoplasms / diagnostic imaging
  • Thymus Neoplasms / pathology*
  • Time Factors
  • Tomography, X-Ray Computed / methods
  • Tumor Burden*

Supplementary concepts

  • Thymic epithelial tumor